Additionally, there is growing evidence that oxytocin-based interventions, such as intranasal oxytocin administration, may have therapeutic potential in alleviating some symptoms of BPD, particularly those related to interpersonal functioning and emotional dysregulation. The gene discussed is OXT; the disease is Abnormal emotional state.